Essex Investment Management’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-72,377
Closed -$1.62M 396
2016
Q4
$1.62M Buy
72,377
+30,016
+71% +$587K 0.27% 102
2016
Q3
$787K Sell
42,361
-990
-2% -$18.7K 0.13% 203
2016
Q2
$707K Sell
43,351
-477
-1% -$7.02K 0.12% 196
2016
Q1
$512K Sell
43,828
-6,987
-14% -$78.1K 0.09% 223
2015
Q4
$594K Sell
50,815
-3,657
-7% -$46.3K 0.09% 219
2015
Q3
$667K Buy
54,472
+2,853
+6% +$36.4K 0.11% 193
2015
Q2
$487K Sell
51,619
-1,086
-2% -$10K 0.07% 230
2015
Q1
$466K Sell
52,705
-395
-0.7% -$3.99K 0.07% 241
2014
Q4
$533K Sell
53,100
-8,420
-14% -$72.2K 0.08% 213
2014
Q3
$413K Sell
61,520
-57,535
-48% -$403K 0.06% 243
2014
Q2
$854K Sell
119,055
-23,957
-17% -$191K 0.13% 200
2014
Q1
$1.44M Buy
143,012
+14,592
+11% +$134K 0.21% 147
2013
Q4
$1.02M Buy
128,420
+7,025
+6% +$65.6K 0.14% 192
2013
Q3
$1.2M Buy
+121,395
New +$955K 0.18% 151

Other funds holding BEAT

Essex Investment Management's BEAT Position: Q1 2017 in Review

Essex Investment Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2017, closing a stake of 72,377 shares — an estimated $1.62M sold.

Essex Investment Management first reported a position in BEAT in Q3 2013 and held it in 14 quarters. The position peaked at $1.62M in Q4 2016. 178 funds tracked by Wall St. Rank hold BEAT as of Q1 2017.

  • Essex Investment Management reported no remaining BioTelemetry, Inc. position as of Q1 2017 after selling out during the quarter.
  • Essex Investment Management sold 72,377 BioTelemetry, Inc. shares in Q1 2017, an estimated $1.62M.
  • Essex Investment Management first reported a position in BioTelemetry, Inc. in Q3 2013 and held it in 14 quarters.
  • Essex Investment Management's BioTelemetry, Inc. position peaked at $1.62M in Q4 2016.
  • 178 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2017.

Based on Essex Investment Management's 13F filing for Q1 2017, filed 27 Apr 2017.